International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 13 , ISSUE 2 ( March-April, 2020 ) > List of Articles

Original Article

Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial

Divya Subramanyam, Sujatha Somasundaram

Keywords : Formocresol, Primary teeth, Pulp therapy, Pulpotomy

Citation Information : Subramanyam D, Somasundaram S. Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial. Int J Clin Pediatr Dent 2020; 13 (2):138-143.

DOI: 10.5005/jp-journals-10005-1724

License: CC BY-NC 4.0

Published Online: 23-07-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. Materials and methods: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups: group II: Buckley's FC, group II: Aloe vera gel. The clinical and radiographic success were evaluated using Zurn and Seale criteria. The data were statistically analyzed using the Chi-square test. Results: At three and 6 months follow-up, the clinical success rate of Aloe vera and FC was equally effective. Aloe vera showed a higher radiographic success rate compared to FC (p > 0.05). At 6 months follow-up, FC showed a higher radiographic success rate compared to Aloe vera (p > 0.05). Conclusion: The clinical and radiographic success of both groups were equally effective at the end of 6 months follow-up. Aloe vera can be considered as an alternative pulpotomy medicament to FC. But, further long-term follow-up studies and histological studies are required.

  1. Airen P, Shigli A, Airen B. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars—2-year follow-up. J Clin Pediatr Dent 2012;37(2):143–147. DOI: 10.17796/jcpd.37.2.h427vr8157444462.
  2. Subay RK, Ilhan B, Ulukapi H. Mineral trioxide aggregate as a pulpotomy agent in immature teeth: long-term case report. Eur J Dent 2013;7(1):133–138.
  3. Kundu H, Patthi B, Singla A, et al. Dental caries scenario among 5, 12 and 15-year-old children in India- a retrospective analysis. J Clin Diagn Res 2015;9(7):ZE01–ZE05. DOI: 10.7860/JCDR/2015/12439.6150.
  4. Togoo R, Nasim V, Zakirulla M, et al. Knowledge and practice of pulp therapy in deciduous teeth among general dental practitioners in Saudi Arabia. Ann Med Health Sci Res 2012;2(2):119–123. DOI: 10.4103/2141-9248.105657.
  5. Ghoddusi J, Forghani M, Parisay I. New approaches in vital pulp therapy in permanent teeth. Iran Endod J 2014;9(1):15–22.
  6. Fuks AB. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives. J Endod 2008;34(7 Suppl):S18–S24. DOI: 10.1016/j.joen.2008.02.031.
  7. Ford TR, Torabinejad M, Abedi HR, et al. Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc 1939;127(10):1491–1494. DOI: 10.14219/jada.archive.1996.0058.
  8. Coll JA. Indirect pulp capping and primary teeth: is the primary tooth pulpotomy out of date? Pediatr Dent 2008;30(3):230–236. DOI: 10.1016/j.joen.2008.02.033.
  9. Cameron AC, Widmer RP. Handbook of Pediatric Dentistry. Elsevier Health Sciences; 2008.
  10. Holan G, Fuks AB, Ketlz N. Success rate of formocresol pulpotomy in primary molars restored with stainless steel crown vs amalgam. Pediatr Dent 2002;24(3):212–216.
  11. Ranly DM. Pulpotomy therapy in primary teeth: new modalities for old rationales. Pediatr Dent 1994;16(6):403–409.
  12. Sweet CA. Treatment of vital primary teeth with pulpal involvement. Therapeutic pulpotomy. J Colorado D A 1955;33:10–14.
  13. Yildiz E, Tosun G. Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies. Eur J Dent 2014;8(2):234–240. DOI: 10.4103/1305-7456.130616.
  14. Ranly DM, Garcia-Godoy F. Reviewing pulp treatment for primary teeth. J Am Dent Assoc 1991;122(9):83–85. DOI: 10.14219/jada.archive.1991.0263.
  15. Sabbarini J, Mounir M, Dean J. Histological evaluation of enamel matrix derivative as a pulpotomy agent in primary teeth. Pediatr Dent 2007;29(6):475–479.
  16. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs formocresol in pulpotomized primary molars: a preliminary report. Pediatr Dent 2001;23(1):15–18.
  17. Fei AL, Udin RD, Johnson RA. Clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 1991;13(6):327–332.
  18. Fuks AB. Pulp therapy for the primary and young permanent dentitions. Dent Clin North Am 2000;44(3):571–596.
  19. Fuks AB, Holan G, Davis JM, et al. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up. Pediatr Dent 1997;19(5):327–330.
  20. Goyal P, Pandit IK, Gugnani N, et al. Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: a randomized clinical trial. Eur J Dent 2016;10(3):315–320. DOI: 10.4103/1305-7456.184144.
  21. Wright FA, Widmer RP. Pulpal therapy in primary molar teeth: a retrospective study. J Pedod 1979;3(3):195–206.
  22. Parisay I, Ghoddusi J, Forghani M. A review on vital pulp therapy in primary teeth. Iran Endod J 2015;10(1):6–15.
  23. Chandrashekhar S, Shashidhar J. Formocresol, still a controversial material for pulpotomy: a critical literature review. J Restor Dent 2014;2(3):114–124. DOI: 10.4103/2321-4619.143594.
  24. Ng FK, Messer LB. Mineral trioxide aggregate as a pulpotomy medicament: a narrative review. Eur Arch Paediatr Dent 2008;9(1):4–11. DOI: 10.1007/BF03321589.
  25. Sirohi K, Marwaha M, Gupta A, et al. Comparison of clinical and radiographic success rates of pulpotomy in primary molars using ferric sulfate and bioactive tricalcium silicate cement: an in vivo study. Int J Clin Pediatr Dent 2017;10(2):147–151. DOI: 10.5005/jp-journals-10005-1425.
  26. Myers DR, Shoaf HK, Dirksen TR, et al. Distribution of 14C-formaldehyde after pulpotomy with formocresol. J Am Dent Assoc 1978;96(5):805–813. DOI: 10.14219/jada.archive.1978.0187.
  27. Subramanyam D, Somasundaram S. Clinical and radiographic outcome of herbal medicine versus standard pulpotomy medicaments in primary molars: a systematic review. J Clin Diagn Res 2017;11(10):ZE12–ZE16. DOI: 10.7860/JCDR/2017/30878.10716.
  28. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol 2008;53(4):163–166. DOI: 10.4103/0019-5154.44785.
  29. Khairwa A, Bhat M, Sharma R, et al. Clinical and radiographic evaluation of zinc oxide with Aloe vera as an obturating material in pulpectomy: an in vivo study. J Indian Soc Pedod Prev Dent 2014;32(1):33–38. DOI: 10.4103/0970-4388.127051.
  30. Davis RH, Donato JJ, Hartman GM, et al. Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. J Am Podiatr Med Assoc 1994;84(2):77–81. DOI: 10.7547/87507315-84-2-77.
  31. Gupta N, Bhat M, Devi P, et al. Aloe-cera: a nature's gift to children. Int J Clin Pediatr Dent 2010;3(2):87–92. DOI: 10.5005/jp-journals-10005-1059.
  32. Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002;3(3):115–120.
  33. Verco PJW, Allen KR. Formocresol pulpotomies in primary teeth. J Int Assoc Dent Child 1984;15(1):51–55.
  34. Heilig J, Yates J, Siskin M, et al. Calcium hydroxide pulpotomy for primary teeth: a clinical study. J Am Dent Assoc 1984;108(5):775–778. DOI: 10.14219/jada.archive.1984.0049.
  35. Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc 1981;103(3):429–434. DOI: 10.14219/jada.archive.1981.0341.
  36. Casas MJ, Kenny DJ. Do we still need formocresol in pediatric dentistry? J Can Dent Assoc 2005;71(10):749–751.
  37. Tyler V. The honest herbal: A sensible guide to the use of herbs and related remedies, 3rd ed., Binghamton, New York: Pharmaceutical Products Press; 1993.
  38. Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev 2012;6(11):1–5. DOI: 10.4103/0973-7847.95849.
  39. Gontijo S, Gomes A, Gala-Garcia A, et al. Evaluation of antimicrobial activity and cell viability of Aloe vera sponges. Electron J Biotechnol 2013;16(1):2. DOI: 10.2225/vol16-issue1-fulltext-2.
  40. Gala-Garcia A, Teixiera KIR, Mendes LL, et al. Effect of Aloe vera on rat pulp tissue. Pharm Biol 2008;46(5):302–308. DOI: 10.1080/13880200801887138.
  41. Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules 2008;13(8):1599–1616. DOI: 10.3390/molecules13081599.
  42. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol 1999;68(1–3):30–37. DOI: 10.1016/S0378-8741(99)00085-9.
  43. Elavarasu S, Naveen D, Thangavelu A. Lasers in periodontics. J Pharm Bioallied Sci 2012;4(Suppl 2):S260–S263. DOI: 10.4103/0975-7406.100245.
  44. Kalra M, Garg N, Rallan M, et al. Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12-month follow-up study. Contemp Clin Dent 2017;8(1):106–111. DOI: 10.4103/ccd.ccd_874_16.
  45. Zurn D, Seale NS. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatr Dent 2008;30(1):34–41.
  46. Estrela C, Holland R, de Araújo Estrela CR, et al. Characterization of successful root canal treatment. Braz Dent J 2014;25(1):3–11. DOI: 10.1590/0103-6440201302356.
  47. Mortazavi H, Baharvand M. Review of common conditions associated with periodontal ligament widening. Imaging Sci Dent 2016;46(4):229–237. DOI: 10.5624/isd.2016.46.4.229.
  48. Peng L, Ye L, Tan H, et al. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(6):e40–e44. DOI: 10.1016/j.tripleo.2006.05.017.
  49. Hugar SM, Reddy R, Deshpande SD, et al. In vivo comparative evaluation of mineral trioxide aggregate and formocresol pulpotomy in primary molars: a 60-month follow-up study. Contemp Clin Dent 2017;8(1):122–127. DOI: 10.4103/ccd.ccd_849_16.
  50. Sonmez D, Durutürk L. Ca(OH)2 pulpotomy in primary teeth. Part I: internal resorption as a complication following pulpotomy. Oral Surg Oral Med Oral Pathol 2008;106(2):e94–e98. DOI: 10.1016/j.tripleo.2008.04.008.
  51. Mohammad SG, Raheel SA, Baroudi K. Clinical and radiographic evaluation of Allium sativum oil as a new medicament for vital pulp treatment of primary teeth. J Int Oral Health 2014;6(6):32–36.
  52. Yaman E, Görken F, Pinar Erdem A, et al. Effects of folk medicinal plant extract Ankaferd Blood Stopper (®) in vital primary molar pulpotomy. Eur Arch Paediatr Dent 2012;13(4):197–202. DOI: 10.1007/BF03262870.
  53. Purohit RN, Bhatt M, Purohit K, et al. Clinical and radiological evaluation of turmeric powder as a pulpotomy medicament in primary teeth: an in vivo study. Int J Clin Pediatr Dent 2017;10(1):37–40. DOI: 10.5005/jp-journals-10005-1404.
  54. Cuisia ZE, Musselman R, Schneider P, et al. A study of mineral trioxide aggregate pulpotomies in primary molars. Pediatr Dent 2001;23:16.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.